Community vaccination center, Covid-19, Pain, SARS-CoV-2, Self-reported adverse reactions, Severe allergic reactions, Systemic reactions
Multimorbidity, COVID-19, Long-COVID, Vaccination, Public Health, Primary Health Care
Biosimilar, Interrupted Time-Series Analysis, Quasi experiment, Infliximab, Consumption, Listed Price, Drug policy, Economics
penumococcal vaccine strategy, vaccine benefits, cardiovascular disease, population-based retrospective cohort study, healthcare big data, real-world evidence, geriatrics